If you are wondering how natural history studies are relevant to cell and gene therapy development, listen as Chris Kenwood, Principal Statistician with Veristat, takes us through an introduction. Learn how natural history studies provide evidence for identifying patient subgroups that may benefit from therapy, help in identifying or developing biomarkers, assist in establishing clinical outcome assessments, and more.
